BioLife Solutions, Inc.

NASDAQ:BLFS

Medical - Instruments & Supplies

Healthcare
$38.61 +1.56%

+$0.40 today

Market cap
$1.89B
Beta
1.97
P/E (TTM)
-119.9
EPS (TTM)
-$0.22
52W Low $17.86High $29.62

Volume 4.39M

Average 0.52M

BLFS Tax Assets

Deferred tax assets that can reduce taxes payable in future periods.

BioLife Solutions, Inc.NASDAQ: BLFS

Tax Assets · Q1 FY2026 · quarter ended Mar 2026

Tax assets remains negative

Q1 FY2026 tax assets was $0, compared with $0 a year earlier.

Context

  • Tax assets amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Tax assets increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Tax Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Tax Assets history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Tax Assets vs competitors

How BLFS compares with its peers on the latest reported figures

  • BLFS's Mar 2026 tax assets of $0 is the 4th highest of the 11 companies compared; the peer median is $0.
  • Tax assets amounts to 0.0% of total assets for BLFS, versus a peer median of 0.0%.
BLFS Competitors Peer median
Tax Assets for BLFS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PHRPhreesia, Inc.Apr 2026$1.59M —+169.9%0.2%
STAASTAAR Surgical CompanyApr 2026$1.09M -72.8%+15.0%0.2%
AZTAAzenta, Inc.Sep 2026$499K -31.3%-4.4%0.0%
BLFSBioLife Solutions, Inc.Mar 2026$0 ——0.0%
PLSEPulse Biosciences, Inc.Jun 2026$0 —-16.7%0.0%
NEOGNeogen CorporationAug 2026$0 ——0.0%
ATRCAtriCure, Inc.Jun 2026$0 ——0.0%
ESTAEstablishment Labs Holdings Inc.Sep 2026$0 ——0.0%
NVCRNovoCure LimitedMar 2026$0 ——0.0%
KMTSKestra Medical Technologies, Ltd.Jan 2026$0 ——0.0%
HROWHarrow Health, Inc.Mar 2026$0 ——0.0%
Peer median (excluding BLFS) $0-52.0%+5.3%0.0%

Competitors are the stored peer set for BLFS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents69.87M19.44M27.9M95.39M33.04M
Short-term Investments043.26M16.29M9.2M55.89M
Net Receivables23.22M33.94M18.66M9.17M7.95M
Inventory28.35M34.9M43.46M29.01M30.16M
Other Current Assets(229K)6.91M14.31M6M9.53M
Total Current Assets125.86M138.45M120.6M148.76M136.56M
Property, Plant & Equipment (Net)36.8M39.2M32.62M16.76M22.18M
Goodwill224.74M224.74M224.74M212.3M208.59M
Intangible Assets152.15M32.09M21.15M9.56M4.26M
Long-term Investments4.37M6.4M13.33M5.62M31.25M
Tax Assets(1.13M)021.15M00
Other Non-current Assets9.81M9.35M(20.88M)6.48M3.05M
Total Non-current Assets426.75M311.78M292.11M250.73M269.32M
Total Assets552.6M450.23M412.71M399.49M405.88M
Account Payables14.95M15.37M6.94M3.57M1.49M
Short-term Debt862K1.81M6.29M10.94M5M
Tax Payables27K5.13M6M4.26M0
Deferred Revenue814K548K661K103K195K
Other Current Liabilities21.52M20.71M23.21M5.23M5.93M
Total Current Liabilities42.7M44.58M42.18M32.73M22.98M
Long-term Debt6.35M23.79M17.56M5M0
Deferred Tax Liabilities5.49M250K114K124K189K
Deferred Revenue (Non-current)(1.66M)0000
Other Non-current Liabilities4.94M2.33M6.5M78K171K
Total Non-current Liabilities33.54M41.46M32.87M17.84M11.02M
Total Liabilities76.24M86.04M75.05M50.58M34M
Common Stock42K43K45K47K48K
Retained Earnings(105.02M)(246.92M)(313.34M)(335.1M)(339.7M)
Accumulated OCI(282K)(679K)(345K)24K132K
Other Stockholders Equity00000
Minority Interest00000
Total Equity480.75M364.19M337.66M348.91M371.89M
Total Debt26.88M43.71M33.83M30.17M17.9M
Net Debt(42.99M)24.27M5.93M(65.21M)(15.14M)

BioLife Solutions, Inc.

NASDAQ:BLFS

Intrinsic Alpha fair value

Locked

Current Price

$38.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.